Navigation Links
The International Myeloma Foundation Says New Clinical Trial,Results Could Improve Survival While Reducing Side Effects For Many,Patients

the IMF, added, "These findings may also have wider implications for cancer treatments because they challenge the traditional notion that patients should be treated with the highest dose of medicine they can tolerate. Now we have evidence that in some situations, less may be more when treating cancer."

REVLIMID from the Celgene Corporation is the newest of the group of medicines called novel therapies that have significantly improved the outlook for patients with myeloma. Preliminary analysis of the ECOG data shows patients taking REVLIMID plus low dose dexamethasone had a 96% survival rate after one year with a reduced risk of side effects. One year survival for those taking the higher dose of dexamethasone was 86%. The findings are expected to prompt review of the dexamethasone dose when paired with other medications used in myeloma such as THALOMID(R), and discussions are already underway to change dosing in other clinical trials using REVLIMID with dexamethasone.

"This is a very exciting finding for patients," said Michael Katz, who, as a 16-year myeloma survivor, is a vice president of the IMF and co-chair of ECOG's Patient Representatives Committee. "When ECOG's patient representatives proposed adding a lower dose 'dex' arm to this trial, we were just looking for a way to make the treatment more tolerable; we never expected that the outcome for patients would actually improve. We are grateful to all of the patients who participated and to ECOG Group chair, Dr. Robert Comis and Myeloma Committee chair, Dr. Vincent Rajkumar, for supporting the notion of testing lower doses and making this trial happen."

Mr. Katz continued: "This result sends an important signal to physicians that maximum tolerated dose is not always the right answer when treating patients with cancers like myeloma that are incurable, but highly treatable."

Myeloma, also called multiple myeloma, is a cancer of the bone marrow that affects production of red cells, white
'"/>




Page: 1 2 3

Related medicine technology :

1. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
6. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
7. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
8. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
9. Labopharm to Present Poster on Dose Titration of Once-daily Tramadol at 3rd International Forum on Pain Medicine
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
Post Your Comments:
(Date:5/27/2015)... CITY, Calif. , May 27, 2015  Genomic Health, ... Cole , Chief Operating Officer and Chief Financial Officer, will ... New York City on Monday, June 1 ... the live and subsequently archived webcast of the presentation, go ... at http://investor.genomichealth.com .  Please connect to the web site ...
(Date:5/27/2015)... May 25, 2015 Research and Markets ... "Research and Future Development Trend Forecast of China ... At present, there are 35,600 dialysis centers in ... are large due to the different regional operating entities: ... in other Asian countries are operated by state-owned medical ...
(Date:5/27/2015)... 27, 2015  Relmada Therapeutics, Inc. (OTCQB: RLMD), a ... chronic pain, announced today that it will present at ... 1, 2015 at the Luxe Sunset Hotel in ... The presentation by Michael Becker , Relmada,s senior ... to begin at 2:00 p.m. PT/5:00 p.m. ET. A ...
Breaking Medicine Technology:Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3China Dialysis Market Report: Research and Future Development Trends and Forecasts 2015-2020 2Relmada Therapeutics to Present at the 2015 LD Micro Invitational Conference 2Relmada Therapeutics to Present at the 2015 LD Micro Invitational Conference 3
... 25, 2011 Newport Audiology Centers announced ... Colorado, to Nashville, Tennessee. The new Nashville Operations Center ... its key partners and expand operations across their consumer, ... are very excited by the opportunities Nashville will bring," ...
... China, July 25, 2011 /PRNewswire-Asia/ -- The whole healthcare ... technology trends and social economic increases. Generally speaking, several ... rapid increase of world population especially the aging ... are increasing in both developed and developing countries. They ...
Cached Medicine Technology:Avoid Illness Through Easy Daily Check 2
(Date:5/27/2015)... The news is full of companies getting fined, ... or appropriate training: an automobile manufacturer, a store in ... in Texas and the list goes on. The Feds ... to improper training and documentation (Osha.gov). eLeaP Learning ... new Supervisor feature which provides a powerful tool for ...
(Date:5/27/2015)... May 27, 2015 Altec Products, Inc., ... announced today their Premier Sponsorship of Connections 2015. The ... Hilton on Thursday, May 28th and will deliver to ... well as the roadmap to get there. , ... in the sale, installation and support of Intacct Cloud ...
(Date:5/27/2015)... Harbor, MD (PRWEB) May 27, 2015 ... will attend this year’s conference of the American Immigration ... at the Gaylord National Resort. MCA’s booth is #404. ... Annual Gathering in Immigration Law.” MCAads.com, a regular AILA ... family meeting” as they welcome current clients to their ...
(Date:5/27/2015)... The Society for Women's Health Research ... research on sex differences in health and disease, today ... advocates, organizations, and celebrities in bringing awareness to the ... campaign features a short film that shares the stories ... as a result of their abuse, as well as ...
(Date:5/27/2015)... 27, 2015 A. Joshua Halpern, MD, ... the addition of UltraShape® , a revolutionary body-shaping ... his Tampa Plastic Surgery Center. , ... the first and only non-invasive body shaping treatment that ... fat, without harming the surrounding tissue, vasculature, nerves or ...
Breaking Medicine News(10 mins):Health News:New Supervisor Feature Streamlines HR Compliance Reporting and Documentation 2Health News:New Supervisor Feature Streamlines HR Compliance Reporting and Documentation 3Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 2Health News:Altec Sponsors Connections 2015, Arxis Technology, Inc.’s Client Conference, Bringing Valuable Document Management Solution to Attendees 3Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 2Health News:PERM Specialists from MCAads.com Will Attend the 2015 Conference on Immigration Law Set for June 17-20 in the DC Metro Area 3Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 2Health News:The Society for Women’s Health Research Announces “Beyond the Bruises” Campaign Highlighting the Effects of Domestic Violence on Chronic Disease 3Health News:Tampa Plastic Surgery Center Delivers A Better Way To A Better Body 2Health News:Tampa Plastic Surgery Center Delivers A Better Way To A Better Body 3
... 23 Alexandra Rundlett and Gregory Laslo will travel ... 31, 2009 to meet with congressional leaders and gain ... research toward a cure for epilepsy.Rundlett, 10, and Laslo, ... in Kids Speak Up! , a national program ...
... SAN FRANCISCO, March 23 Blue Shield of California ... Tuesday, promoting Rob Geyer and Janet Widmann to senior ... previous changes announced by chairman and CEO Bruce Bodaken ... chief operating officer. Geyer, previously vice president of ...
... possess an enzyme deficiency that causes their skin to ... from the National Institute on Alcohol Abuse and Alcoholism ... heavy alcohol consumption greatly increases the risk for esophageal ... of the world,s population. Their review of recent research ...
... Claire Kenney of Boise, Idaho, will travel to Washington, ... to meet with congressional leaders and gain their support ... a cure for epilepsy.Kennedy, 16, is one of 37 ... Kids Speak Up! , a national program coordinated by ...
... UnionEAST PROVIDENCE, R.I., March 23 IlluminOss Medical ... IlluminOss(TM) Photodynamic Bone Stabilization System for orthopedic surgery, ... CE Mark. The approval permits the Company ... (EU).IlluminOss Medical is beginning the process of selecting ...
... March 23 Kiley Carlson of Sioux City, IA ... Tuesday, March 31, 2009 to meet with congressional leaders ... and more research toward a cure for epilepsy.Carlson, 16, ... country participating in Kids Speak Up! , a ...
Cached Medicine News:Health News:Maryland Youths Share Epilepsy Message on Capitol Hill 2Health News:Blue Shield of California Names Two New Senior Vice Presidents 2Health News:Alcohol 'flush' signals increased cancer risk among East Asians 2Health News:Alcohol 'flush' signals increased cancer risk among East Asians 3Health News:Idaho Youth Shares Epilepsy Message on Capitol Hill 2Health News:IlluminOss(TM) Photodynamic Bone Stabilization System Receives CE Mark 2Health News:Iowa Youth Shares Epilepsy Message on Capitol Hill 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: